149 related articles for article (PubMed ID: 35912877)
41. Dosimetric evaluation of photons versus protons in postmastectomy planning for ultrahypofractionated breast radiotherapy.
Oonsiri P; Nantavithya C; Lertbutsayanukul C; Sarsitthithum T; Vimolnoch M; Tawonwong T; Saksornchai K
Radiat Oncol; 2022 Jan; 17(1):20. PubMed ID: 35093111
[TBL] [Abstract][Full Text] [Related]
42. Photons, protons or carbon ions for stage I non-small cell lung cancer - Results of the multicentric ROCOCO in silico study.
Wink KCJ; Roelofs E; Simone CB; Dechambre D; Santiago A; van der Stoep J; Dries W; Smits J; Avery S; Ammazzalorso F; Jansen N; Jelen U; Solberg T; de Ruysscher D; Troost EGC
Radiother Oncol; 2018 Jul; 128(1):139-146. PubMed ID: 29545019
[TBL] [Abstract][Full Text] [Related]
43. Potential role of intensity-modulated photons and protons in the treatment of the breast and regional nodes.
Lomax AJ; Cella L; Weber D; Kurtz JM; Miralbell R
Int J Radiat Oncol Biol Phys; 2003 Mar; 55(3):785-92. PubMed ID: 12573766
[TBL] [Abstract][Full Text] [Related]
44. TriB-RT: Simultaneous optimization of photon, electron and proton beams.
Kueng R; Mueller S; Loebner HA; Frei D; Volken W; Aebersold DM; Stampanoni MFM; Fix MK; Manser P
Phys Med Biol; 2021 Feb; 66(4):045006. PubMed ID: 32413883
[TBL] [Abstract][Full Text] [Related]
45. Practical robustness evaluation in radiotherapy - A photon and proton-proof alternative to PTV-based plan evaluation.
Korevaar EW; Habraken SJM; Scandurra D; Kierkels RGJ; Unipan M; Eenink MGC; Steenbakkers RJHM; Peeters SG; Zindler JD; Hoogeman M; Langendijk JA
Radiother Oncol; 2019 Dec; 141():267-274. PubMed ID: 31492443
[TBL] [Abstract][Full Text] [Related]
46. Radiotherapy treatment of early-stage prostate cancer with IMRT and protons: a treatment planning comparison.
Trofimov A; Nguyen PL; Coen JJ; Doppke KP; Schneider RJ; Adams JA; Bortfeld TR; Zietman AL; Delaney TF; Shipley WU
Int J Radiat Oncol Biol Phys; 2007 Oct; 69(2):444-53. PubMed ID: 17513063
[TBL] [Abstract][Full Text] [Related]
47. A treatment planning comparison of intensity modulated photon and proton therapy for paraspinal sarcomas.
Weber DC; Trofimov AV; Delaney TF; Bortfeld T
Int J Radiat Oncol Biol Phys; 2004 Apr; 58(5):1596-606. PubMed ID: 15050341
[TBL] [Abstract][Full Text] [Related]
48. Exploratory Study of 4D versus 3D Robust Optimization in Intensity Modulated Proton Therapy for Lung Cancer.
Liu W; Schild SE; Chang JY; Liao Z; Chang YH; Wen Z; Shen J; Stoker JB; Ding X; Hu Y; Sahoo N; Herman MG; Vargas C; Keole S; Wong W; Bues M
Int J Radiat Oncol Biol Phys; 2016 May; 95(1):523-533. PubMed ID: 26725727
[TBL] [Abstract][Full Text] [Related]
49. On the benefits and risks of proton therapy in pediatric craniopharyngioma.
Beltran C; Roca M; Merchant TE
Int J Radiat Oncol Biol Phys; 2012 Feb; 82(2):e281-7. PubMed ID: 21570209
[TBL] [Abstract][Full Text] [Related]
50. Comparison of linear and nonlinear programming approaches for "worst case dose" and "minmax" robust optimization of intensity-modulated proton therapy dose distributions.
Zaghian M; Cao W; Liu W; Kardar L; Randeniya S; Mohan R; Lim G
J Appl Clin Med Phys; 2017 Mar; 18(2):15-25. PubMed ID: 28300378
[TBL] [Abstract][Full Text] [Related]
51. Intensity-modulated radiotherapy of nasopharyngeal carcinoma: a comparative treatment planning study of photons and protons.
Taheri-Kadkhoda Z; Björk-Eriksson T; Nill S; Wilkens JJ; Oelfke U; Johansson KA; Huber PE; Münter MW
Radiat Oncol; 2008 Jan; 3():4. PubMed ID: 18218078
[TBL] [Abstract][Full Text] [Related]
52. Proton therapy - Present and future.
Mohan R; Grosshans D
Adv Drug Deliv Rev; 2017 Jan; 109():26-44. PubMed ID: 27919760
[TBL] [Abstract][Full Text] [Related]
53. Dosimetric comparison of protons vs photons in re-irradiation of intracranial meningioma.
Poel R; Stuessi Lobmaier A; Andratschke N; Unkelbach J; Tanadini-Lang S; Guckenberger M; Foerster R
Br J Radiol; 2019 Aug; 92(1100):20190113. PubMed ID: 31264474
[TBL] [Abstract][Full Text] [Related]
54. Robustly optimized hybrid intensity-modulated proton therapy for craniospinal irradiation.
Noufal MP; Sharma SD; Krishnan G; Sawant M; Gaikwad U; Jalali R
J Cancer Res Ther; 2022; 18(6):1597-1603. PubMed ID: 36412417
[TBL] [Abstract][Full Text] [Related]
55. The rationale for intensity-modulated proton therapy in geometrically challenging cases.
Safai S; Trofimov A; Adams JA; Engelsman M; Bortfeld T
Phys Med Biol; 2013 Sep; 58(18):6337-53. PubMed ID: 23965339
[TBL] [Abstract][Full Text] [Related]
56. Potential proton and photon dose degradation in advanced head and neck cancer patients by intratherapy changes.
Stützer K; Jakobi A; Bandurska-Luque A; Barczyk S; Arnsmeyer C; Löck S; Richter C
J Appl Clin Med Phys; 2017 Nov; 18(6):104-113. PubMed ID: 28921843
[TBL] [Abstract][Full Text] [Related]
57. Robustness analysis of CTV and OAR dose in clinical PBS-PT of neuro-oncological tumors: prescription-dose calibration and inter-patient variation with the Dutch proton robustness evaluation protocol.
Rojo-Santiago J; Habraken SJM; Romero AM; Lathouwers D; Wang Y; Perkó Z; Hoogeman MS
Phys Med Biol; 2023 Aug; 68(17):. PubMed ID: 37494944
[No Abstract] [Full Text] [Related]
58. Dosimetric comparison between carbon, proton and photon radiation for renal retroperitoneal soft tissue sarcoma recurrence or metastasis after radical nephrectomy.
Ming X; Wang W; Shahnazi K; Sun J; Zhang Q; Li P; Hong Z; Sheng Y
Int J Radiat Biol; 2022; 98(2):183-190. PubMed ID: 34802361
[TBL] [Abstract][Full Text] [Related]
59. Comparison of photon volumetric modulated arc therapy, intensity-modulated proton therapy, and intensity-modulated carbon ion therapy for delivery of hypo-fractionated thoracic radiotherapy.
Chi A; Lin LC; Wen S; Yan H; Hsi WC
Radiat Oncol; 2017 Aug; 12(1):132. PubMed ID: 28810881
[TBL] [Abstract][Full Text] [Related]
60. Effect of setup and inter-fraction anatomical changes on the accumulated dose in CT-guided breath-hold intensity modulated proton therapy of liver malignancies.
Yang Z; Chang Y; Brock KK; Cazoulat G; Koay EJ; Koong AC; Herman JM; Park PC; Poenisch F; Li Q; Yang K; Wu G; Anderson B; Ohrt AN; Li Y; Zhu XR; Zhang X; Li H
Radiother Oncol; 2019 May; 134():101-109. PubMed ID: 31005203
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
